Cargando…
Comparison of the Uroflowmetry Parameter Results Between Transgender Males Undergoing Gender-Affirming Hormone Therapy and Age-Matched Cisgender Females: Preliminary Data
Purpose: Gender-affirming hormone therapy (GHT) using testosterone is administered to transgender males. Although various effects caused by hormonal therapy have been reported, those on lower urinary tract function have remained unclear. The present study compared the uroflowmetry (UFM) parameter re...
Autores principales: | Matsuo, Kazuna, Ichihara, Koji, Gotoh, Momokazu, Masumori, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637770/ https://www.ncbi.nlm.nih.gov/pubmed/31321304 http://dx.doi.org/10.1089/trgh.2019.0025 |
Ejemplares similares
-
Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
por: Masumori, Naoya, et al.
Publicado: (2023) -
Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men
por: Kirisawa, Takahiro, et al.
Publicado: (2021) -
Gender essentialism in transgender and cisgender children
por: Gülgöz, Selin, et al.
Publicado: (2019) -
Brain connectivity dynamics in cisgender and transmen people with gender incongruence before gender affirmative hormone treatment
por: Uribe, Carme, et al.
Publicado: (2021) -
Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)